SCHEMBL3485016

SCHEMBL3485016

O=C(O)c1ccc(CCC(C=Cc2ccccc2OCc2ccc(CCc3ccccc3)cc2)Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.54
PTGER4 P35408 2/20 0.54
PTGER3 P43115 2/20 0.54
PTGER2 P43116 2/20 0.54
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 3/20 0.53
MAPT P10636 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 2/20 0.53
CRHBP P24387 2/20 0.53
CRHR2 Q13324 2/20 0.53
PSMD14 O00487 1/20 0.53
PPARG P37231 1/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
RXRA P19793 7/20 0.47
RXRB P28702 6/20 0.47
RXRG P48443 5/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485013 1.00 PTGER1 (0.54) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL8243864 0.95 PTGER1 (0.49) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL13498116 0.91 RXRA (0.51) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3485351 0.90 PTGER1 (0.49) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3485347 0.90 PTGER1 (0.49) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL13498117 0.90 RXRA (0.50) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3484771 0.90 RXRA (0.50) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3484769 0.90 RXRA (0.50) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3484264 0.89 PTGER1 (0.48) PTGER1PTGER4PTGER3PTGER2KMT2A
SCHEMBL3484259 0.89 PTGER1 (0.48) PTGER1PTGER4PTGER3PTGER2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 PTGER1 2299/4885PTGER4 2636/4885PTGER3 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.